PDCD1 and cancer: Since PD-1-/- profoundly attenuated hindlimb ischemia-induced angiogenesis, and since PD-1 blocking antibodies are often used for cancer treatment, we further determined the effect of PD-1 blocking antibodies on hindlimb ischemia-induced angiogenesis in WT mice (Figures 7A-E).